Brainsway Ltd. (BRSYF)
OTC
Closed
Aug 24, 2026
Day's Range
13.5452 wk Range
5.49Overview - BRSYF - Brainsway Ltd.
Key Statistics
Valuation
Enterprise Value
530.77M
P/E (Trailing)
‪65.78‬
P/E (Forward)
‪116.38‬
PEG Ratio
‪0.65‬
Price / Sales (TTM)
‪10.01‬
Price / Book
‪7.39‬
EV / EBITDA
‪62.56‬
Profitability
Gross Margin
‪75.17%‬
Profit Margin
‪15.55%‬
Operating Margin
‪13.97%‬
Return on Assets
‪4.04%‬
Return on Equity
‪12.81%‬
Ownership
Shares Outstanding
40.03M
Float
23.19M
Held by Insiders
‪9.50%‬
Held by Institutions
‪10.70%‬
Price stats
Beta
‪0.09‬
50-Day Avg
‪15.75‬
200-Day Avg
‪12.79‬
Dividends
Payout Ratio
‪0.00%‬
Peers - BRSYF - Brainsway Ltd.
Peer Comparison
Compared with companies in Medical Devices listed on OTC.
- BRSYFOTCBrainsway Ltd.608.05MMarket Cap+63.71%52-week change65.78P/E (Trailing)‪15.55%‬Profit Margin
- SEMHFOTCSiemens Healthineers AG53.26BMarket Cap-16.57%52-week change20.69P/E (Trailing)‪9.55%‬Profit Margin
- SMMNYOTCSiemens Healthineers AG Unsponsored ADR52.66BMarket Cap-16.98%52-week change20.36P/E (Trailing)‪9.55%‬Profit Margin
- RYLPFOTCKoninklijke Philips N.V.26.95BMarket Cap+1.81%52-week change20.74P/E (Trailing)‪6.30%‬Profit Margin
- SONVYOTCSonova Holding AG ADR17.96BMarket Cap+5.56%52-week change26.92P/E (Trailing)‪11.94%‬Profit Margin
- OCPNFOTCOlympus Corporation14.02BMarket Cap+10.15%52-week change33.85P/E (Trailing)‪7.49%‬Profit Margin
- SNNUFOTCSmith & Nephew plc12.95BMarket Cap-11.76%52-week change20.92P/E (Trailing)‪10.07%‬Profit Margin
Profile Summary - BRSYF - Brainsway Ltd.
About
Brainsway Ltd. is a pioneering medical device company that focuses on the development and distribution of advanced brain stimulation solutions. Its primary function is to provide non-invasive treatments for a variety of neuropsychiatric disorders, including depression and obsessive-compulsive disorder (OCD), using…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
